↓ Skip to main content

Dove Medical Press

Ipilimumab in the treatment of metastatic melanoma: management of adverse events

Overview of attention for article published in OncoTargets and therapy, February 2014
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

patent
1 patent

Citations

dimensions_citation
88 Dimensions

Readers on

mendeley
76 Mendeley
Title
Ipilimumab in the treatment of metastatic melanoma: management of adverse events
Published in
OncoTargets and therapy, February 2014
DOI 10.2147/ott.s57335
Pubmed ID
Authors

Giuseppina Della Vittoria Scarpati, Celeste Fusciello, Francesco Perri, Francesco Sabbatino, Soldano Ferrone, Chiara Carlomagno, Stefano Pepe

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 76 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 1%
Ecuador 1 1%
Korea, Republic of 1 1%
Unknown 73 96%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 17 22%
Researcher 12 16%
Student > Master 8 11%
Student > Ph. D. Student 5 7%
Student > Doctoral Student 4 5%
Other 14 18%
Unknown 16 21%
Readers by discipline Count As %
Medicine and Dentistry 29 38%
Agricultural and Biological Sciences 11 14%
Biochemistry, Genetics and Molecular Biology 9 12%
Nursing and Health Professions 1 1%
Mathematics 1 1%
Other 5 7%
Unknown 20 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 January 2023.
All research outputs
#8,534,976
of 25,373,627 outputs
Outputs from OncoTargets and therapy
#547
of 3,016 outputs
Outputs of similar age
#97,812
of 322,718 outputs
Outputs of similar age from OncoTargets and therapy
#5
of 23 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,016 research outputs from this source. They receive a mean Attention Score of 2.9. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 322,718 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 23 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.